Načítá se...
Ipratropium bromide versus short acting beta‐2 agonists for stable chronic obstructive pulmonary disease
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a condition associated with high morbidity, mortality and cost to the community. Patients often report symptomatic improvement with short‐acting beta‐2 agonists (SABA) and anticholinergic bronchodilator medications, and both are recommended...
Uloženo v:
| Vydáno v: | Cochrane Database Syst Rev |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Ltd
2006
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6513456/ https://ncbi.nlm.nih.gov/pubmed/16625543 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD001387.pub2 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|